Updates are available Correction dated 2024-12-13
Click to view Correction: https://doi.org/10.1038/s41593-024-01855-5
-
Authors
Marsh, Samuel E. https://orcid.org/0000-0002-3012-6945
Walker, Alec J.
Kamath, Tushar
Dissing-Olesen, Lasse
Hammond, Timothy R.
de Soysa, T. Yvanka
Young, Adam M. H.
Murphy, Sarah
Abdulraouf, Abdulraouf
Nadaf, Naeem https://orcid.org/0000-0002-7805-8523
Dufort, Connor
Walker, Alicia C.
Lucca, Liliana E.
Kozareva, Velina
Vanderburg, Charles https://orcid.org/0000-0001-8979-5054
Hong, Soyon https://orcid.org/0000-0002-5744-4871
Bulstrode, Harry
Hutchinson, Peter J.
Gaffney, Daniel J.
Hafler, David A. https://orcid.org/0000-0003-4664-535X
Franklin, Robin J. M. https://orcid.org/0000-0001-6522-2104
Macosko, Evan Z. https://orcid.org/0000-0002-2794-5165
Stevens, Beth https://orcid.org/0000-0003-4226-1201
- License Information
-
More Information
Article History
Received: 2 December 2020
Accepted: 25 January 2022
First Online: 8 March 2022
Change Date: 13 December 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41593-024-01855-5
Competing interests
: The authors declare no competing interests. Though we believe that none of these relationships are conflicts of interest, D.A.H. has received research funding from Bristol Myers Squibb, Sanofi and Genentech for work unrelated to this project. He has been a consultant over the past 10 years for Bristol Myers Squibb, Compass Therapeutics, EMD Serono, Genentech, Juno Therapeutics, Novartis Pharmaceuticals, Proclara Biosciences, Sage Therapeutics and Sanofi Genzyme.
